vTv Therapeutics (VTVT) Non Operating Income (2014 - 2026)

vTv Therapeutics has disclosed Non Operating Income across 11 years of filings, most recently posting $9000.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at $9000.0, up 132.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $27000.0 (down 86.01% YoY), and the FY2025 annual result was -$27000.0, up 82.0% from the prior year.
• Non Operating Income came in at $9000.0 for Q1 2026 at vTv Therapeutics, down from $12000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.9 million in Q4 2022 to a low of -$3.2 million in Q1 2022.
• The 5-year median for Non Operating Income is $12000.0 (2025), against an average of $55875.0.
• Across the five-year window, Non Operating Income surged 522.08% in 2022 and sank 107.79% in 2025, its largest moves.
• vTv Therapeutics' Non Operating Income stood at $3.9 million in 2022, then slumped by 99.57% to $17000.0 in 2023, then jumped by 35.29% to $23000.0 in 2024, then slumped by 47.83% to $12000.0 in 2025, then declined by 25.0% to $9000.0 in 2026.
• The last three Non Operating Income figures came in at $9000.0 (Q1 2026), $12000.0 (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.